Literature DB >> 23208466

Antimicrobial and cytotoxic isohexenylnaphthazarins from Arnebia euchroma (Royle) Jonst. (Boraginaceae) callus and cell suspension culture.

Harilaos Damianakos1, Nadine Kretschmer, Katarzyna Sykłowska-Baranek, Agnieszka Pietrosiuk, Rudolf Bauer, Ioanna Chinou.   

Abstract

The phytochemical investigation of the n-hexane extract from callus and cell suspension culture of Arnebia euchroma (Royle) Jonst. resulted in the isolation of nine isohexenylnaphthazarins: deoxyalkannin (1), alkannin (2), acetylalkannin (3), isobutyrylalkannin (4), β-hydroxyisovalerylalkannin (5), 2''-(S)-α-methylbutyrylalkannin (6), propionylalkannin (7), teracrylalkannin (8) and acetylshikonin (9). Their structures were determined by MS and NMR spectroscopy. Pigments 2–8 are isolated for the first time from Arnebia in vitro cultures, 4 and 7 are reported in the present work as novel metabolites within the Arnebia genus, while 9 is a known constituent of both natural roots and in vitro cultures of A. euchroma. Moreover, methyl jasmonate and 1-monoglyceryl olate, palmitate and stearate are reported for the first time within the Boraginaceae family. The antimicrobial and cytotoxic activities of all isolated pigment compounds were tested, revealing a very interesting profile.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23208466      PMCID: PMC6268811          DOI: 10.3390/molecules171214310

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


1. Introduction

Alkannin, shikonin and related isohexenylnaphthazarin compounds are natural lipophilic red pigments that occur in many species of the Boraginaceae family. The chiral pairs of alkannins/shikonins are potent pharmaceutical substances that have shown significant biological activities including wound healing, antimicrobial, antiinflammatory, antioxidant, anticancer and antithrombotic properties [1,2,3,4]. Because of the importance of the alkannin/shikonin-related compounds in the pharmaceutical and cosmetic industry, cultivation of Boraginaceous species, including the genus Arnebia, have been studied using biotechnological approaches. Arnebia euchroma (Royle) Jonst. tissue culture was pioneered in Russia due to the plant’s high content of shikonin/alkannin derivatives [5]. In this study we were focused on the isolation of isohexenylnaphthazarin compounds from callus culture and cell suspension culture of A. euchroma, elucidation of their structures by modern spectral techniques and the evaluation of their antimicrobial and cytotoxic activities.

2. Results and Discussion

2.1. Isolation of Isohexenylnaphthazarin Pigments

Isohexenylnaphthazarin pigments are well known constituents of certain plants of the Boraginaceae family [1,6,7,8,9,10,11,12,13,14,15]. The stereochemistry of the herein isolated isohexenylnaphthazarins was assigned to be of the alkannin type, except for acetylshikonin (Figure 1), on the basis of their negative specific rotation values [9,14], albeit in different solvents and at slightly different temperatures from those of the literature.
Figure 1

Chemical structures of compounds isolated from callus and cell suspension cultures of A. euchroma.

Regarding their natural abundance within the Arnebia genus, a review of the literature lead to the following findings: (a) compound 1 is abundant in the roots of various Arnebia species, including A. euchroma, and has also been isolated from cell cultures of the latter species [1]; (b) compound 2 is found in the roots of A. hispidissima, A. nobilis, A. tinctoria [1,15] and A. euchroma [13]; (c) compound 3 is found in the roots of A. euchroma, A. hispidissima and A. nobilis [1]; (d) compound 4 is not contained either in the natural roots or in any cell culture so far; (e) compound 5 occurs in the roots of A. euchroma and A. hispidissima [1]; (f) compound 6 occurs in the roots of A. densiflora [13,14,16] and A. euchroma [13]; (g) compound 7 is not produced in either natural roots or in in vitro cultures; (h) compound 8 is found in the roots of A. densiflora [15]; (i) compound 9 is a known constituent of both natural roots and in vitro cultures of A. euchroma [1]. Apart from naphthoquinone pigments, linoleic acid [17] and β-sitosterol [18] have been identified in both in vitro cultures. Additionally, methyl linolate [17] has been isolated from the cell suspension culture (also detected by GC-MS in the roots of other Boraginaceous species [19,20]) as well as methyl jasmonate (10) [21,22] (for the first time within the Boraginaceae family), a triglyceride mixture of palmitic, stearic and 8-Ζ- or 9-Ζ- or 11-Ζ or 9-Ε-octadecenoic acid (as determined after transesterification/methylation and GC-MS analysis of the resulting fatty acid methyl esters [23]) and also a mixture of 1-monoglycerides of palmitic, stearic and oleic acid (as determined after transesterification/methylation and GC-MS analysis of the resulting fatty acid methyl esters [23], as well as after GC-MS analysis of the silylated derivatives which were identified as 2,3-O-bis(trimethylsilyl)-1-glyceryl palmitate, stearate and oleate respectively) probably for the first time within Boraginaceae family. Chemical structures of compounds isolated from callus and cell suspension cultures of A. euchroma.

2.2. Antimicrobial Activity

According to our results (Table 1) the n-hexane extract of both callus and cell suspension culture of A. euchroma, showed a very interesting broad antimicrobial profile against all the assayed microorganisms, while among the pure tested compounds the most active compounds were alkannin, acetylshikonin, β-hydroxyisovalerylalkannin and isobutyrylalkannin. It is noteworthy that acetylshikonin was much more active in comparison with its enantiomer acetylalkannin.
Table 1

Antimicrobial activities of extracts and isolated compounds (1–9) from A. euchroma (n = 3).

Zone of inhibition in cm
S. aureus S. epidermidis P. aeruginosa K. pneumoniae E. cloacae E. coli C. albicans C. tropicalis C. glabrata
A. euchroma (callus n-hexane extract)151512111111101112
A. euchroma (cell suspension culture n-hexane extract)161613121212121313
1 12121110111291010
2 151412111112111214
3 1011101010991010
4 141313111112101213
5 151513131214111212
6 131212111112101112
7 121311121211101111
8 121112101011101111
9 151412121111121113
Metilmycin 222420252322---
Amoxicillin with clavulanic acid 212125232224---
5-Flucytocine ------222422
Amphotericin B ------232424
Antimicrobial activities of extracts and isolated compounds (1–9) from A. euchroma (n = 3).

2.3. Cytotoxic Activities

To study the cytotoxicity of the isolated naphthoquinone derivatives, they were subjected to a viability assay using different cancer cell lines. IC50 values of active compounds were determined (Figure 2 and Table 2). Among 1–9, 6 showed the highest activity against all assayed cancer cell lines and was even more active than 2 which is believed to be the most active isohexenylnaphthazarine. Compounds 3 and 4 also exhibited higher cytotoxicity than 2, while 1, 5, 7 and 8 exhibited similar IC50 values, with the exception of 7, which was not active against U251 cells up to 100 µM. Our results indicate that the naphthoquinone moiety is more important for activity than the side chain and that the side chain is a kind of modulator of the activity, an assumption that was also made by Cui et al. [24]. Similar observations were also made by Papageorgiou [25] concerning antimicrobial activity. Lu et al. [26] reported that also the chiral center does not affect activity. Our findings support this because 1, which lacks the chiral center, showed comparable activity with the other derivatives and the activities of enantiomers 3 and 9 did not differ significantly.
Figure 2

Cytotoxic activities of isolated alkannin derivatives determined by the XTT viability assay. Results represent mean ± sem, n = 4. Numbers correspond to the isolated compounds (1–8).

Table 2

IC50 values of isolated alkannin derivatives (1–8), acetylshikonin (9) and vinblastine (VBN) against different cancer cell lines. Mean ± SEM, n = 4.

CompoundIC50 (µM)
CCRF-CEMMDA-MB-231U251HCT 116
1 2.31 ± 0.2713.34 ± 1.3515.01 ± 1.168.39 ± 1.20
2 1.67 ± 0.3827.59 ± 8.2541.70 ± 5.856.53 ± 0.87
3 0.98 ± 0.056.22 ± 0.4619.17 ± 1.431.52 ± 0.05
4 0.53 ± 0.025.60 ± 0.3616.39 ± 0.455.64 ± 0.14
5 3.32 ± 0.7412.07 ± 0.1369.70 ± 17.6712.50 ± 1.05
6 0.39 ± 0.024.62 ± 0.143.17 ± 0.311.75 ± 0.06
7 1.22 ± 0.2430.05 ± 5.92>100 µM7.97 ± 0.84
8 1.69 ± 0.1512.21 ± 0.8825.84 ± 0.666.83 ± 0.85
9 1.01 ± 0.0911.33 ± 1.6515.86 ± 0.679.02 ± 0.51
VBN 9.4 × 10−3 ± 2 × 10−43.1 × 10−2 ± 4.6 × 10−38.1 × 10−3 ± 1.0 × 10−38.7 × 10−3 ± 5.0 × 10−4
Cytotoxic activities of isolated alkannin derivatives determined by the XTT viability assay. Results represent mean ± sem, n = 4. Numbers correspond to the isolated compounds (1–8). IC50 values of isolated alkannin derivatives (1–8), acetylshikonin (9) and vinblastine (VBN) against different cancer cell lines. Mean ± SEM, n = 4.

3. Experimental

3.1. Chemicals and Reagents

Silica gel 60 and TLC plates Kieselgel 60, 0.2 mm layer thickness, were purchased from Merck Chemical Co. (Darmstadt, Germany). Bands on TLC plates were detected under UV light (254 and 366 nm) and/or after spraying with a 2.5% H2SO4 and 2.5% vanillin methanolic solutions and heating at 105 °C for 5 min. Dichloromethane was used as an extraction solvent for the compound bands obtained from preparative TLC, using 20 cm × 20 cm plates each one loaded with ≤15 mg of sample. Solvents including n-hexane, cyclohexane, ethyl acetate, dichloromethane, diethyl ether and toluene were purchased from Lab Scan Ltd (Dublin, Ireland). BSTFA (N,O-bis(trimethylsilyl)trifluoroacetamide) was purchased from Merck (Darmstadt, Germany).

3.2. Instruments and Methods

The GC-MS analysis was performed with a Hewlett Packard Gas Chromatograph 5890 Series II Plus linked to a Hewlett Packard 5972 mass spectrometer system equipped with a 30 m long × 0.25 mm i.d. and 0.5 µm film thickness HP5-MS capillary column. The temperature was programmed from 100 to 300 °C at a rate of 4 °C/min. Helium was used as a carrier gas, flow rate 0.7 mL/min. Split ratio 1:20, injector temperature 220 °C, ionization voltage 70 eV. Silylated samples for GC were obtained after addition of excess of BSTFA in pyridine followed by heating at 80 °C for 20 min. ESI-MS spectra were obtained using a 3200 QTRAP LC/MS/MS Applied Biosystems mass spectrometer using an ion spray voltage of +4,500 V, declustering potential of 50 V and entrance potential of 10V. 1H- and 13C-1D, HSQC, and COSY 2D-NMR spectra were recorded on Bruker Avance 400 and 200 MHz FT-NMR spectrometers. [α]Dvalues were measured in dichloromethane using a Perkin Elmer 341 polarimeter.

3.3. Plant Callus and Cell Suspension Culture

Callus tissue of A. euchroma was maintained on MSA solid medium [5] (50 mL) in 300 mL Erlenmeyer flasks. The medium was supplemented with kinetin (1.0 mg/L) and IAA (0.3 mg/L) prior to autoclaving at 121 °C for 20 min and solidified with 0.8% of DIFCO agar. The cell suspension culture was established by transferring callus tissue into liquid MSA medium and kept on an INFORS AG TR 250 shaker at 105 rpm. Every four weeks 1.5 ± 0.05 g fresh weight of cell aggregates were placed into 250 mL Erlenmeyer flasks containing 50 mL of fresh MSA medium. The callus and cell suspension cultures were cultivated at 25 °C in the dark.

3.4. Extraction and Isolation

Lyophilized callus tissue (65.97 g dry weight) and cells from cell suspension culture (47.73 g dry weight) of A. euchroma were extracted for 5 days with n-hexane in a Soxhlet apparatus. The solvent was evaporated in vacuo and the deep red semi-solid residues (0.91 g from the cell suspension culture and 0.59 g from the callus culture) were examined by TLC for their contents. These extracts were subjected to silica gel column chromatography using gradients of cyclohexane/EtOAc (100:0 → 0:100%) and 26 fractions (A–Z) were collected for the cell suspension extract. Some of these fractions were further subjected to preparative TLC: fraction A (207.2 mg) developed with cyclohexane/Et2O/AcOH 97/2/1 afforded 1 (11.4 mg) and methyl linolate (2.2 mg); fraction E (171.8 mg) developed with cyclohexane/EtOAc/AcOH 90/9/1 afforded 6 (45 mg) as well as a mixture of fatty acid triglycerides (10 mg). 1 mg of the latter was subjected to transesterification/methylation using TMSH (trimethylsulfonium hydroxide) and the obtained fatty acid methyl esters were identified by GC-MS as methyl palmitate (42.8%), methyl stearate (14.7%) and methyl 8-Z- or 9-Z- or 9-E- or 11-Z-octadecanoate (42.5%); fractions G and H (74.4 mg) developed with cyclohexane/Et2O/AcOH 87/12/1 afforded 4 (15 mg) and 7 (4.9 mg); L and M (326 mg) developed with cyclohexane/EtOAc/AcOH 85/14/1 afforded 3 (82.6 mg), linoleic acid (8.0 mg) and β-sitosterol (9.7 mg); fraction P (47 mg) developed twice with cyclohexane/EtOAc/AcOH 92/7/1 afforded 10 (6.9 mg). Fractions S and T (37.3 mg) developed with PhMe/EtOAc/AcOH 95/4/1 afforded 2 (3.8 mg) and 8 (2.6 mg); U-W (37.2 mg) developed with cyclohexane/ EtOAc/AcOH 80/19/1 yielded 5 (7.8 mg); finally Z (31.8 mg) developed twice with cyclohexane/EtOAc/AcOH 65/34/1 afforded a mixture of 1-monoglycerides (6.1 mg). 1 mg of the latter was subjected to transesterification/methylation using TMSH and the obtained fatty acid methyl esters were identified by GC-MS as methyl palmitate (69.2%), methyl stearate (16.9%) and methyl olate (13.9%). In addition, silylation of a small amount of the 1-monoglyceride mixture lead to the corresponding mixture of the bis(trimethylsilyl) derivatives, which after GC-MS analysis were identified as 2,3-O-bis(trimetylsilyl)-1-monoesters of glycerol with palmitic acid (73.8%), oleic acid (8.9%) and stearic acid (17.3%). Likewise, 20 fractions (A–T) were collected for the callus culture extract, after the initial silica gel column chromatography using the same elution procedure. Some of these fractions were further subjected to preparative TLC: fraction A (152.3 mg) was developed with cyclohexane/Et2O/AcOH 97/2/1 and afforded 1 (7.6 mg); E-H (141.8 mg) were developed twice with PhMe/AcOH 99/1 and afforded 4 (8.8 mg) and 6 (29.6 mg); finally K, L, M, developed with cyclohexane/EtOAc/AcOH 85/14/1 afforded 9 (41.4 mg) and also GC-MS examination of two other zones revealed the presence of linoleic acid and β-sitosterol.

3.5. Compound Characterization

All structures were identified by MS (samples dissolved in methanol) and NMR spectroscopy. Deoxyalkannin (1); deep red semi-solid; 1H-NMR (400 MHz, CDCl3) δ 1.60 (3H, s, H-6'), 1.70 (3H, s, H-5'), 2.31 (2H, m, H-2'), 2.64 (2H, t, J = 7.6 Hz, H-1'), 5.14 (1H, t, J = 7.2 Hz, H-3'), 6.84 (1H, s, H-3), 7.21 (2H, s, H-6 and H-7), 12.48 and 12.64 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 17.8 (C-6'), 25.6 (C-5'), 26.5 (C-2'), 29.7 (C-1'), 111.7 and 111.9 (C-9 and C-10), 122.3 (C-3'), 130.9 and 131.1 (C-6 and C-7), 133.6 (C-4'), 134.5 (C-3), 151.5 (C-2), 162.3 and 162.9 (C-5 and C-8), 183.0 (C-1 and C-4); ESI-MS m/z 273 [M+H]+. Alkannin (2); deep red semi-solid; [α]25: −164 (c = 0.01583); 1H-NMR (400 MHz, CDCl3) δ 1.66 (3H, s, H-6'), 1.76 (3H, s, H-5'), 2.36 and 2.65 (2 × 1H, 2 × m, H-2'), 4.92 (1H, dd, J = 4.1 and 7.6 Hz, H-1'), 5.21 (1H, t, J = 7.3 Hz, H-3'), 7.18 (1H, s, H-3), 7.21 (2H, s, H-6 and H-7), 12.51 and 12.61 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 18.1 (C-6'), 25.9 (C-5'), 35.7 (C-2'), 68.4 (C-1'), 111.6 and 112.0 (C-9 and C-10), 118.5 (C-3'), 131.9 (C-3), 132.3 and 132.4 (C-6 and C-7), 137.4 (C-4'), 151.4 (C-2), 164.9 and 165.6 (C-5 and C-8), 179.8 and 180.6 (C-1 and C-4); ESI-MS m/z 289 [M+H]+. Acetylalkannin (3); deep red semi-solid; [α]25: −772 (c = 0.00136); 1H-NMR (400 MHz, CDCl3) δ 1.56 (3H, s, H-6'), 1.68 (3H, s, H-5'), 2.13 (3H, s, H-2''), 2.46 and 2.60 (2 × 1H, 2 × m, H-2'), 5.11 (1H, t, J = 7.3 Hz, H-3'), 6.00 (1H, dd, J = 4.6 and 7.1 Hz, H-1'), 6.97 (1H, s, H-3), 7.16 (2H, s, H-6 and H-7), 12.40 and 12.56 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 17.8 (C-6'), 20.8 (C-2''), 25.6 (C-5'), 32.7 (C-2'), 69.4 (C-1'), 111.4 and 111.7 (C-9 and C-10), 117.6 (C-3'), 131.4 (C-3), 132.5 and 132.7 (C-6 and C-7), 135.9 (C-4'), 148.1 (C-2), 166.7 and 167.2 (C-5 and C-8), 169.6 (C-1''), 176.7 and 178.2 (C-1 and C-4); ESI-MS m/z 331 [M+H]+. Isobutyrylalkannin (4); deep red semi-solid; [α]25: −515 (c = 0.00136); 1H-NMR (400 MHz, CDCl3) δ 1.20 (6H, d, J = 7.1 Hz, H-3'' and H-4''), 1.58 (3H, s, H-6'), 1.68 (3H, s, H-5'), 2.46 and 2.63 (2 × 1H, 2 × m, H-2'), 2.65 (1H, m, H-2''), 5.12 (1H, t, J = 7.3 Hz, H-3'), 6.01 (1H, dd, J = 4.6 and 7.2 Hz, H-1'), 6.97 (1H, s, H-3), 7.18 (2H, s, H-6 and H-7), 12.43 and 12.58 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 17.9 (C-6'), 18.8 and 18.9 (C-3'' and C-4''), 25.7 (C-5'), 32.9 (C-2'), 34.0 (C-2''), 69.0 (C-1'), 111.5 and 111.7 (C-9 and C-10), 117.8 (C-3'), 131.3 (C-3), 132.6 and 132.8 (C-6 and C-7), 136.1 (C-4'), 148.7 (C-2), 166.7 and 166.9 (C-5 and C-8), 175.7 (C-1''), 176.8 and 178.3 (C-1 and C-4); ESI-MS m/z 359 [M+H]+. β-hydroxyisovalerylalkannin (5); deep red semi-solid; [α]25: −147 (c = 0.00136); 1H-NMR (400 MHz, CDCl3) δ 1.30 and 1.31 (2 × 3H, 2 × s, H-4'' and H-5''), 1.59 (3H, s, H-6'), 1.69 (3H, s, H-5'), 2.51 and 2.62 (2 × 1H, 2 × m, H-2'), 2.59 (2H, s, H-2''), 5.12 (1H, t, J = 6.7 Hz, H-3'), 6.09 (1H, dd, J = 4.6 and 7.2 Hz, H-1'), 7.02 (1H, s, H-3), 7.18 (2H, s, H-6 and H-7), 12.42 and 12.60 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 17.9 (C-6'), 25.7 (C-5'), 29.1 and 29.2 (C-4'' and C-5''), 32.9 (C-2'), 46.5 (C-2''), 69.1 (C-3''), 69.8 (C-1'), 111.6 and 111.8 (C-9 and C-10), 117.6 (C-3'), 131.3 (C-3), 133.1 and 133.3 (C-6 and C-7), 136.4 (C-4'), 147.5 (C-2), 168.2 and 168.7 (C-5 and C-8), 171.7 (C-1''), 175.3 and 176.9 (C-1 and C-4); ESI-MS m/z 389 [M+H]+. 2''-(S)-α-Methylbutyrylalkannin (6); deep red semi-solid; [α]25: −368 (c = 0.00136); 1H-NMR (400 MHz, CDCl3) δ 0.90 (3H, t, J = 7.5 Hz, H-4''), 1.17 (3H, d, J = 7.0 Hz, H-5''), 1.49 and 1.69 (2 × 1H, 2 × m, H-3''), 1.58 (3H, s, H-6'), 1.68 (3H, s, H-5'), 2.43 (1H, m, H-2''), 2.45 and 2.60 (2 × 1H, 2 × m, H-2'), 5.12 (1H, t, J = 7.5 Hz, H-3'), 6.02 (1H, dd, J = 4.5 and 7.5 Hz, H-1'), 6.98 (1H, s, H-3), 7.16 (2H, s, H-6 and H-7), 12.42 and 12.58 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 11.6 (C-4''), 16.6 (C-5''), 17.9 (C-6'), 25.7 (C-5'), 26.6 (C-3''), 33.0 (C-2'), 41.2 (C-2''), 69.0 (C-1'), 111.6 and 111.8 (C-9 and C-10), 117.8 (C-3'), 131.4 (C-3), 132.7 and 132.8 (C-6 and C-7), 136.0 (C-4'), 148.6 (C-2), 166.8 and 167.3 (C-5 and C-8), 175.3 (C-1''), 176.8 and 178.3 (C-1 and C-4); ESI-MS m/z 373 [M+H]+. Propionylalkannin (7); deep red semi-solid; [α]25: −221 (c = 0.00136); 1H-NMR (400 MHz, CDCl3) δ 1.17 (3H, t, J = 7.6 Hz, H-3''), 1.58 and 1.69 (2 × 3H, 2 × s, H-5' and H-6'), 2.43 (2H, q, J = 7.6 Hz, H-2''), 2.47 and 2.62 (2 × 1H, 2 × m, H-2'), 5.12 (1H, m, H-3'), 6.03 (1H, m, H-1'), 6.98 (1H, d, J = 1.0 Hz, H-3), 7.19 (2H, s, H-6 and H-7), 12.44 and 12.60 (2 × 1H, 2 × s, OH); 13C-NMR (50 MHz, CDCl3) δ 9.0 (C-3''), 17.9 (C-6'), 25.8 (C-5'), 27.6 (C-2''), 32.8 (C-2'), 69.2 (C-1'), 111.6 and 111.8 (C-9 and C-10), 117.7 (C-3'), 131.4 (C-3), 132.7 and 132.8 (C-6 and C-7), 136.0 (C-4'), 148.4 (C-2), 166.8 and 167.3 (C-5 and C-8), 173.2 (C-1''), 176.8 and 178.3 (C-1 and C-4); ESI-MS m/z 345 [M+H]+. Teracrylalkannin (8); deep red semi-solid; [α]25: −521 (c = 0.00192); 1H-NMR (400 MHz, CDCl3) δ 1.53 and 1.56 (2 × 3H, 2 × s, H-6'' and H-7''), 1.57 and 1.68 (2 × 3H, 2 × s, H-5' and H-6'), 2.00 (3H, s, H-5''), 2.47 and 2.61 (2 × 1H, 2 × m, H-2'), 2.94 and 3.02 (2 × 1H, 2 × d, J = 14.4 Hz, H-2''), 5.12 (1H, t, J = 7.0 Hz, H-3'), 6.03 (1H, dd, J = 4.4 and 7.2 Hz, H-1'), 7.01 (1H, s, H-3), 7.18 (2H, s, H-6 and H-7), 12.42 and 12.59 (2 × 1H, 2 × s, OH); ESI-MS, m/z 399 [M+H]+. Acetylshikonin (9); deep red semi-solid; [α]25: + 692 (c = 0.00136), same spectral data as for acetylalkannin (3). Methyl jasmonate (10); 1H-NMR (400 MHz, CDCl3) δ 0.95 (3H, t, J = 7.5 Hz), 1.88 (1H, m), 2.00–2.45 (10H, m), 2.71 (1H, m), 3.69 (3H, s), 5.25 (1H, m), 5.45 (1H, m); 13C-ΝΜR (50 MHz, CDCl3) δ 13.3, 20.7, 25.6, 27.3, 37.8, 38.1, 38.9, 51.7, 54.1, 125.1, 134.2, 172.4, 218.8.

3.6. Antimicrobial Activity

3.6.1. Microbial Strains

A total of nine microorganisms were assayed among which two Gram-positive bacteria: Staphylococcus aureus (ATCC 25923), Staphylococcus epidermidis (ATCC 12228) and the four Gram-negative bacteria: Escherichia coli (ATCC 25922), Enterobacter cloacae (ATCC 13047), Klebsiella pneumoniae (ATCC 13883) and Pseudomonas aeruginosa (ATCC 227853) as well as the pathogen fungi Candida albicans (ATCC 10231), C. tropicalis (ATCC 13801) and C. glabrata (ATCC 28838).

3.6.2. Antimicrobial Assays

Antimicrobial activity was evaluated using the disc diffusion method by measuring the zone of inhibition. Standard antibiotics netilmicin and 5-flucytocine (Sanofi, Diagnostics Pasteur, Lake Hazeltine Drive Chaska, MT, USA) were used in order to control the sensitivity of the tested bacteria and fungi, respectively. The tested compounds were dissolved in MeOH. For each experiment control disc with pure solvent was used as blind control. All paper discs had a diameter of 6 mm and were deposited on the surface of the seeded trypticase soy agar Petri dishes. The plates were inoculated with the organisms of interest to give a final cell concentration of 107 cells/mL and incubated for 48 h at 37 °C. The fungi were grown on Sabouraud’s agar at 25 °C for 48 h. The experiments were repeated three times and results (diameters in mm) were expressed as mean values [27].

3.7. Cell Culture

Human leukemia cells CCRF-CEM and breast cancer cells MDA-MB-231 were cultured in RPMI 1640 medium (Sigma, St. Louis, MO, USA), 2 mM L-glutamine (Sigma), 10% heat-inactivated fetal bovine serum (FBS, PAA Laboratories, Pasching, Austria) and 1% Pen/Strep. (PAA Laboratories). Human glioblastoma cells U251 and colon cancer cells HCT 116 were grown in Dulbecco’s modified Eagle medium (DMEM, Sigma), 2 mM L-glutamine, 10% FBS and 1% Pen/Strep. All cells were kept in a 5% CO2 atmosphere at 37 °C. At 90% confluence cells were passaged.

3.8. XTT Viability Assay

Cell proliferation kit II (XTT) (Cat. No. 11 465 015 001) was obtained from Roche Diagnostics (Mannheim, Germany). Aliquots (100 µL) of 5 × 104 cells/mL of MDA-MB-231, U251 and HCT 116 cells were seeded in 96-well plates (flat bottom) and grown for 18 h in a humidified 37 °C, 5% CO2 atmosphere before substances were added. Control cells were treated with 0.5% DMSO which had no effect on their growth and viability. In case of CCRF-CEM cells, aliquots (100 µL) of 1 × 105 cells/mL were seeded in 96-well plates (flat bottom) and substances were added immediately. All cells were incubated with the substance of interest for 72 h before XTT solution was added. Vinblastine served as a positive control. XTT is a yellow tetrazolium salt (sodium 3'-[1-(phenylaminocarbonyl)-3,4-tetrazolium]-bis(4-methoxy-6-nitro)benzene sulfonic acid hydrate) and cleaved by metabolic active cells into an orange formazan dye. This colour change occurs only in viable cells and can be directly quantified using a scanning multiwell spectrophotometer [28]. Numbers of viable cells were determined with the following formula expressed as percentage of control: (absorbance of treated cells/absorbance of untreated cells) × 100 [29]. IC50 values were calculated using SigmaPlot 11.0 (Systat Software Inc., San Jose, CA, USA) and the four parameter logistic curve.

4. Conclusions

The n-hexane extract from cell suspension culture of A. euchroma yielded after several chromatographic separations the compounds deoxyalkannin (1), alkannin (2), acetylalkannin (3), isobutyrylalkannin (4), β-hydroxyisovalerylalkannin (5), 2''-(S)-α-methylbutyrylalkannin (6), propionylalkannin (7) and teracrylalkannin (8) along with methyl jasmonate (10), methyl linoleate, linoleic acid, β-sitosterol, a triglyceride mixture of palmitic, stearic and 8-Ζ- or 9-Ζ- or 11-Ζ or 9-Ε-octadecenoic acid and also a mixture of 1-monoglycerides of palmitic, stearic and oleic acid. Likewise from the n-hexane extract of callus culture of A. euchroma the isohexenylnaphthazarins deoxyalkannin (1), isobutyrylalkannin (4), 2''-(S)-α-methylbutyrylalkannin (6) and acetylshikonin (9) were obtained after several separations. In addition linoleic acid and β-sitosterol were identified after GC-MS analysis of some fractions. Among them 4 and 9 are novel for the Arnebia genus while naphthoquinones 2–8 are isolated from A. euchroma in vitro cultures for the first time. Furthermore 10 and the 1-monoglycerides of palmitic, stearic and oleic acid are probably reported for the first time within Boraginaceae family. As regards the tested antimicrobial activity of 1–9, 2, 4, 5 and 9 where the most active against all the assayed microorganisms while acetylshikonin (9) was found much more active than its enantiomer acetylalkannin (3). Compound 6 exhibited the most potent cytotoxic activity against the tested cancer cell lines while it was estimated that the structure of the side chain or its chirality have a minor effect on their cytotoxic activity.
  17 in total

1.  Cyclooxygenase-2 inhibitory effects and composition of the volatile oil from the dried roots of Lithospermum erythrorhizon.

Authors:  Jyunichi Kawata; Munekazu Kameda; Mitsuo Miyazawa
Journal:  J Nat Med       Date:  2008-01-11       Impact factor: 2.343

2.  Terpenes with antimicrobial activity from Cretan propolis.

Authors:  Milena P Popova; Ioanna B Chinou; Ilko N Marekov; Vassya S Bankova
Journal:  Phytochemistry       Date:  2009-08-19       Impact factor: 4.072

3.  Biosynthesis of beta-sitosterol and stigmasterol in Croton sublyratus proceeds via a mixed origin of isoprene units.

Authors:  Wanchai De-Eknamkul; Buppachart Potduang
Journal:  Phytochemistry       Date:  2003-02       Impact factor: 4.072

Review 4.  The Chemistry and Biology of Alkannin, Shikonin, and Related Naphthazarin Natural Products.

Authors:  Vassilios P Papageorgiou; Andreana N Assimopoulou; Elias A Couladouros; David Hepworth; K C Nicolaou
Journal:  Angew Chem Int Ed Engl       Date:  1999-02-01       Impact factor: 15.336

5.  New naphthoquinones from Arnebia hispidissima roots.

Authors:  Y N Shukla; A Srivastava; S C Singh; S Kumar
Journal:  Planta Med       Date:  2001-08       Impact factor: 3.352

6.  Lipids of the hexane extract from the roots of medicinal boraginaceous species.

Authors:  Vassilios P Papageorgiou; Andreana N Assimopoulou
Journal:  Phytochem Anal       Date:  2003 Jul-Aug       Impact factor: 3.373

7.  Simultaneous determination of naphthoquinone derivatives in Boraginaceous herbs by high-performance liquid chromatography.

Authors:  Yani Hu; Zhihong Jiang; Kelvin Sze-Yin Leung; Zhongzhen Zhao
Journal:  Anal Chim Acta       Date:  2006-06-20       Impact factor: 6.558

8.  Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.

Authors:  Xing-Ri Cui; Maiko Tsukada; Nao Suzuki; Takeshi Shimamura; Li Gao; Jyunichi Koyanagi; Fusao Komada; Setsuo Saito
Journal:  Eur J Med Chem       Date:  2007-09-14       Impact factor: 6.514

9.  Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

Authors:  D A Scudiero; R H Shoemaker; K D Paull; A Monks; S Tierney; T H Nofziger; M J Currens; D Seniff; M R Boyd
Journal:  Cancer Res       Date:  1988-09-01       Impact factor: 12.701

10.  Estimation of naphthaquinones from Arnebia hispidissima (Lehm.) DC. In vivo and in vitro. I. Anti-inflammatory screening.

Authors:  B Singh; P M Sahu; S C Jain; S Singh
Journal:  Phytother Res       Date:  2004-02       Impact factor: 5.878

View more
  15 in total

1.  Biological properties of mud extracts derived from various spa resorts.

Authors:  Eliana Spilioti; Margarita Vargiami; Sophia Letsiou; Konstantinos Gardikis; Varvara Sygouni; Petros Koutsoukos; Ioanna Chinou; Eva Kassi; Paraskevi Moutsatsou
Journal:  Environ Geochem Health       Date:  2016-07-21       Impact factor: 4.609

2.  In Silico, Cytotoxic and Antioxidant Potential of Novel Ester, 3-hydroxyoctyl -5- trans-docosenoate Isolated from Anchusa arvensis (L.) M.Bieb. Against HepG-2 Cancer Cells.

Authors:  Sajid Hussain; Farhat Ullah; Muhammad Ayaz; Syed Adnan Ali Shah; Azhar-Ul-Haq Ali Shah; Syed Majid Shah; Abdul Wadood; Waqar Aman; Riaz Ullah; Abdelaaty A Shahat; Fahd A Nasr
Journal:  Drug Des Devel Ther       Date:  2019-12-10       Impact factor: 4.162

3.  Comparing the Healing Effects of Arnebia euchroma Ointment With Petrolatum on the Ulcers Caused by Fractional CO2 Laser: A Single-Blinded Clinical Trial.

Authors:  Jale Aliasl; Fariba Khoshzaban; Behrooz Barikbin; Mohsen Naseri; Mohammad Kamalinejad; Fatemeh Emadi; Zahra Razzaghi; Daryush Talei; Maryam Yousefi; Fatemeh Aliasl; Maryam Barati; Parvaneh Mohseni-Moghaddam; Seyed Abbas Hasheminejad; Hossein Esmailzad Nami
Journal:  Iran Red Crescent Med J       Date:  2014-10-05       Impact factor: 0.611

4.  Inhibition of c-MYC with involvement of ERK/JNK/MAPK and AKT pathways as a novel mechanism for shikonin and its derivatives in killing leukemia cells.

Authors:  Qiaoli Zhao; Andreana N Assimopoulou; Sabine M Klauck; Harilaos Damianakos; Ioanna Chinou; Nadine Kretschmer; José-Luis Rios; Vassilios P Papageorgiou; Rudolf Bauer; Thomas Efferth
Journal:  Oncotarget       Date:  2015-11-17

5.  Shikonin Production by Callus Culture of Onosma bulbotrichom as Active Pharmaceutical Ingredient.

Authors:  Fereshteh Bagheri; Reza Tahvilian; Naser Karimi; Maryam Chalabi; Mahsa Azami
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

6.  Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.

Authors:  Xiaoyue Zhao; Yanan Zhu; Jianhua Hu; Longwei Jiang; Limin Li; Shaochang Jia; Ke Zen
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

7.  Shikonin Inhibits the Proliferation of Human Breast Cancer Cells by Reducing Tumor-Derived Exosomes.

Authors:  Yao Wei; Mingzhen Li; Shufang Cui; Dong Wang; Chen-Yu Zhang; Ke Zen; Limin Li
Journal:  Molecules       Date:  2016-06-16       Impact factor: 4.411

8.  The Mechanism Underlying the Antibacterial Activity of Shikonin against Methicillin-Resistant Staphylococcus aureus.

Authors:  Young-Seob Lee; Dae-Young Lee; Yeon Bok Kim; Sang-Won Lee; Seon-Woo Cha; Hong-Woo Park; Geum-Soog Kim; Dong-Yeul Kwon; Min-Ho Lee; Sin-Hee Han
Journal:  Evid Based Complement Alternat Med       Date:  2015-07-21       Impact factor: 2.629

9.  Liquid perfluorodecalin application for in situ extraction and enhanced naphthoquinones production in Arnebia euchroma cell suspension cultures.

Authors:  Katarzyna Sykłowska-Baranek; Maciej Pilarek; Michał Cichosz; Agnieszka Pietrosiuk
Journal:  Appl Biochem Biotechnol       Date:  2014-01-14       Impact factor: 2.926

10.  Synthesis of Novel Shikonin Derivatives and Pharmacological Effects of Cyclopropylacetylshikonin on Melanoma Cells.

Authors:  Christin Durchschein; Antje Hufner; Beate Rinner; Alexander Stallinger; Alexander Deutsch; Birgit Lohberger; Rudolf Bauer; Nadine Kretschmer
Journal:  Molecules       Date:  2018-10-30       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.